MedPath

Clofibrate

Generic Name
Clofibrate
Drug Type
Small Molecule
Chemical Formula
C12H15ClO3
CAS Number
637-07-0
Unique Ingredient Identifier
HPN91K7FU3

Overview

A fibric acid derivative used in the treatment of hyperlipoproteinemia type III and severe hypertriglyceridemia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986)

Background

A fibric acid derivative used in the treatment of hyperlipoproteinemia type III and severe hypertriglyceridemia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986)

Indication

For Primary Dysbetalipoproteinemia (Type III hyperlipidemia) that does not respond adequately to diet. This helps control high cholesterol and high triglyceride levels.

Associated Conditions

No associated conditions information available.

FDA Approved Products

Product Name
Manufacturer
Route
Strength
Approved
NDC Code

No FDA products found

No FDA products found for this drug

EMA Approved Products

Medicine Name
EMA Number
Auth. Holder
Country
Drug Type
Status
Issued
Opinion
Revision

No EMA products found

No EMA products found for this drug

Singapore Approved Products

Product Name
Manufacturer
Dosage Form
Strength
Approved
Approval No.
Online

No Singapore products found

No Singapore products found for this drug

China Approved Products

Product Name
Approval No.
Manufacturer
Dosage Form
Trade Name
Strength
Type
Status
Date
Import
Clofibrate Capsules
国药准字H11020973
华润双鹤药业股份有限公司
N/A
N/A
0.5g
Chemical Drug
Approved
2010/08/10
Domestic
Clofibrate Capsules
国药准字H21020479
沈阳同联药业有限公司
N/A
N/A
0.25g
Chemical Drug
Approved
2010/08/30
Domestic
Clofibrate Capsules
国药准字H21020442
沈阳同联药业有限公司
N/A
N/A
0.5g
Chemical Drug
Approved
2010/08/30
Domestic
Clofibrate Capsules
国药准字H13022306
河北天成药业股份有限公司
胶囊剂
N/A
0.5g
Chemical Drug
Approved
2002/08/16
Domestic

Australia Approved Products

Product Name
ARTG ID
Sponsor
Status
Reg. Date
Ingredient
COL Capsules
27891
Alphapharm Pty Ltd
Active
1991/10/21
clofibrate
© Copyright 2025. All Rights Reserved by MedPath